Regarding the predictive value of FOLH1 expression for 177Lu-PSMA-617 therapy, our analysis revealed a trend toward longer treatment-related OS in patients with high FOLH1 expression, although this did not reach statistical significance.
← all excerpts
Molecular and clinical correlates of high FOLH1 (PSMA) RNA expression in primary and metastatic prostate cancer.
1
—
—